Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism

Journal of Cellular Physiology

Volumn 216, Issue 3, 2008, Pages 621-631

  Kinney, Erica L ^a,b   Tanida, Satoshi ^a,c   Rodrigue, Amelie A ^b,e   Johnson, Joanna K ^d,f   Tompkins, Van S ^b,g   Sakamuro, Daitoku ^a,h  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

^f Biology Section   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; E1A PROTEIN; ONCOPROTEIN; PROTEIN BIN1; PROTEIN E7; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING; ENZYME INHIBITION; FIBROBLAST; GENE ACTIVITY; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; RODENT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; WART VIRUS; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; HUMANS; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS; RODENTIA;

EID: 48749107576     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21437     Document Type: Article

References (78)

1. Akiyama Y. 1995. TFSEARCH: Searching transcription factor binding sites. http://www.rwcp.or.jp/papia/.
2. Arany Z, Sellers WR, Livingston DM, Eckner R. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
3. Bauer F, Urdaci M, Aigle M, Crouzet M. 1993. Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol Cell Biol 13:5070-5084.
4. Butler MH, David C, Ochoa GC, Freyberg Z, Daniell L, Grabs D, Cremona O, De Camilli P. 1997. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol 137:1355-1367.
5. Cole MD. 1986. The myc oncogene: Its role in transformation and differentiation. Annu Rev Genet 20:361-384.
6. Cole MD, McMahon SB. 1999. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
7. Croxton R, Ma Y, Song L, Haura EB, Cress WD. 2002. Direct repression of the Mcl-1 promoter by E2 F1. Oncogene 21:1359-1369.
8. Culp JS, Webster LC, Friedman DJ, Smith CL, Huang WJ, Wu FY, Rosenberg M, Ricciardi RP. 1988. The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci USA 85:6450-6454.
9. Curran T, Bravo R, Muller R. 1985. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Cancer Surv 4:655-681.
10. Dang CV. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11.
11. Dimova DK, Dyson NJ. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24:2810-2826.
12. Dou QP, Zhao S, Levin AH, Wang J, Helin K, Pardee AB. 1994. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem 269:1306-1313.
13. DuHadaway JB, Sakamuro D, Ewert DL, Prendergast GC. 2001. Bin1 mediates apoptosis by c-Myc in transformed primary cells. Cancer Res 61:3151-3156.
14. DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T, Prendergast GC. 2003. Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: Diverse sites of nuclear expression and losses in prostate cancer. J Cell Biochem 88:635-642.
15. Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC. 1999. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene 18:3564-3573.
16. Elliott K, Ge K, Du W, Prendergast GC. 2000. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19:4669-4684.
17. Evan G. 1997. Cancer - A matter of life and cell death. Int J Cancer 71:709-711.
18. Evan GI, Littlewood TD. 1993. The role of c-myc in cell growth. Curr Opin Genet Dev 3:44-49.
19. Felsani A, Mileo AM, Paggi MG. 2006. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25:5277-5285.
20. Frisch SM, Mymryk JS. 2002. Adenovirus-5 E1A: Paradox and paradigm. Nat Rev Mol Cell Biol 3:441-452.
21. Frolov MV, Dyson NJ. 2004. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117:2173-2181.
22. Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM. 2001. The p400 complex is an essential E1A transformation target. Cell 106:297-307.
23. Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC. 1999. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 96:9689-9694.
24. Ge K, DuHadaway J, Sakamuro D, Wechsler-Reya R, Reynolds C, Prendergast GC. 2000a. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int J Cancer 85:376-383.
25. Ge K, Minhas F, DuHadaway J, Mao NC, Wilson D, Buccafusca R, Sakamuro D, Nelson P, Malkowicz SB, Tomaszewski J, Prendergast GC. 2000b. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 86:155-161.
26. Geng CD, Vedeckis WV. 2005. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J Biol Chem 280:43264-43271.
27. Ghaneie A, Zemba-Palko V, Itoh H, Itoh K, Sakamuro D, Nakamura S, Soler AP, Prendergast GC. 2007. Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. Cancer Biol Ther 6:192-194.
28. Good L, Dimri GP, Campisi J, Chen KY. 1996. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J Cell Physiol 168:S80-S88.
29. Grandori C, Eisenman RN. 1997. Myc target genes. Trends Biochem Sci 22:177-181.
30. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
31. Harlow E, Lane D. 1998. Using antibodies: A laboratory manual. Cold Spring Harbour. NY: Cold Spring Harbour Press.
32. Hermeking H, Eick D. 1994. Mediation of c-Myc-induced apoptosis by pS3. Science 265:2091-2093.
33. Hiebert SW, Lipp M, Nevins JR. 1989. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 86:3594-3598.
34. Hogarty MD, Liu X, Thompson PM, White PS, Sulman EP, Maris JM, Brodeur GM. 2000. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Med Pediatr Oncol 35:S59-562.
35. Hsu B, Marin MC, el-Naggar AK, Stephens LC, Brisbay S, McDonnell TJ. 1995. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11:175-179.
36. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P, Ohgaki H. 2000. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 60:6868-6874.
37. Kaelin WG. 1997. Alterations in G1/S cell-cycle control contributing to carcinogenesis. Ann NY Acad Sci 833:29-33.
38. Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR, Robbins PD. 1992. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12:2455-2463.
39. Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, Ochoa GC, Farsad K, Wenk MR, De Camilli P. 2002. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 297:1193-1196.
40. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. 1993. The Retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13:7813-7825.
41. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13:4070-4079.
42. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. 2004. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416:648-653.
43. Münger K, Scheffner M, Huibregtse JM, Howley PM. 1992. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 12:197-217.
44. Nevins JR. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
45. Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, Kingston H, Garnier JM, Biancalana V, Oldfors A, Mandel JL, Laporte J. 2007. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39:1134-1139.
46. Ohtani K, DeGregori J, Nevins JR. 1995. Regulation of thecyclin E gene by transcription factor E2 F1. Proc Natl Acad Sci USA 92:12146-12150.
47. Okazaki T, Sakamuro D. 2007. Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system. J Cancer Res Clin Oncol 133:581-588.
48. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M, El-Deiry WS. 1998. p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. Int J Oncol 13:5-9.
49. Prendergast GC. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18:2967-2987.
50. Ramalingam A, Prendergast GC. 2007. Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeast. Cell Cycle 6:1655-1662.
51. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. 1994. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9:405-415.
52. Roussel MF, Theodoras AM, Pagano M, Sherr CJ. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc Natl Acad Sci USA 92:6837-6841.
53. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-228.
54. Sakamuro D, Prendergast GC. 1999. New Myc-interacting proteins: A second Myc network emerges. Oncogene 18:2942-2954.
55. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11:2411-2418.
56. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. 1996. BIN1 is a novel MYC-interacting protein with features of a tumor suppressor. Nat Genet 14:69-77.
57. Sakamuro D, Sabbatini P, White E, Prendergast GC. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887-898.
58. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbour, NY: Cold Spring Harbor Press.
59. Samuelson AV, Lowe SW. 1997. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci USA 94:12094-12099.
60. 1/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell Biol 20:3497-3509.
61. Sassoon D, Lyons G, Wright WE, Lin V, Lassar A, Weintraub H, Buckingham M. 1989. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 341:303-307.
62. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 92:10467-10471.
63. Sherr CJ. 1995. Cancer cell cycles. Science 274:1672-1677.
64. Slansky JE, Li Y, Kaelin WG, Farnham PJ. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol 13:1610-1618.
65. Smith DH, Ziff EB. 1988. The amino-terminal region of the adenovirus serotype 5 E1A protein performs two separate functions when expressed in primary baby rat kidney cells. Mol Cell Biol 8:3882-3890.
66. Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, Hogarty MD. 2003. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res 9:3345-3355.
67. Telfer JF, Urquhart J, Crouch DH. 2005. Suppression of MEK/ERK signalling by Myc: Role of Bin1. Cell Signal 17:701-708.
68. Tonini T, Hillson C, Claudio PP. 2002. Interview with the retinoblastoma family members: Do they help each other? J Cell Physiol 192:138-150.
69. Wagner AJ, Kokontis JM, Hay N. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 8:2817-2830.
70. Wang C, Rauscher F III, Cress WD, Chen J. 2007. Regulation of E2F1 function by the nuclear corepressor K API. J Biol Chem 282:29902-29909.
71. Wechsler-Reya R, Elliott K, Herlyn M, Prendergast GC. 1997a. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. Cancer Res 57:32S8-3263.
72. Wechsler-Reya R, Sakamuro D, Zhang J, DuHadaway J, Prendergast GC. 1997b. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem 272:31453-31458.
73. Wechsler-Reya RJ, Elliott KJ, Prendergast GC. 1998. A role for the putative tumor suppressor Bin1 in muscle cell differentiation. Mol Cell Biol 18:566-575.
74. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
75. Weinberg RA. 1996. E2F and cell proliferation: A world turned upside down. Cell 85:457-459.
76. Whyte P, Williamson NM, Harlow E. 1989, Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75.
77. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324.
78. Zhang B, Zelhof AC. 2002. Amphiphysins: Raising the BAR for synaptic vesicle recycling and membrane dynamics. Bin-Amphiphysin-Rvsp. Traffic 3:452-460.